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Research
The advent of DNA microarray technology
has spurred the recent growth of toxicoge-
nomics studies [reviewed in Waters and
Fostel (2004)]. By measuring changes in gene
expression after toxicant exposure on a
genomewide scale, investigators can attempt
to identify genes or pathways involved in the
mechanism of toxicity for that particular toxi-
cant. However, because of the nature of
global gene expression proﬁling, many of the
genes found to be differentially expressed may
not be related to toxicity. For example, some
genes may change because of altered feeding
schedules or diurnal rhythms (Boorman et al.
2005; Kita et al. 2002), whereas other gene
changes may be related to the pharmacology
but not toxicology of the administered sub-
stance. Careful design of toxicogenomics
studies can reduce the complexities of analyz-
ing gene expression data, such as using time-
matched controls to remove those genes for
which expression values change with diurnal
rhythms. In addition, using different doses in
toxicogenomics studies, ranging from phar-
macologic/nontoxic to minimally toxic to
highly toxic, can often identify genes that are
responding to the pharmacologic properties
of the administered toxicant.
Methapyrilene, an antihistaminic com-
pound removed from the U.S. market after it
was found to lead to the development of
hepatic cancers in rats (Lijinsky et al. 1980),
has been the focus of several toxicogenomics
studies (Beekman et al. 2006; Hamadeh et al.
2002; Waring et al. 2004). The Hamadeh
et al. and Waring et al. studies examined
hepatic gene expression in rats treated from 1
to 7 days with methapyrilene at doses of
10 mg/kg and 100 mg/kg, whereas the
Beekman et al. study examined expression
changes in hepatocytes exposed in vitro to
methapyrilene. The Hamadeh et al. study
examined hepatic gene expression  to try to
correlate gene expression changes with alter-
ations in histopathology after methapyrilene
treatment to identify genes involved in
methapyrilene-mediated hepatotoxicity
(Hamadeh et al. 2002). In the Waring et al.
study, the authors demonstrated the robust-
ness of toxicogenomics techniques by showing
that several different sites produced concor-
dant results after performing gene expression
analysis (Waring et al. 2004). Although using
different microarray platforms, both studies
produced similar results in gene expression
changes after methapyrilene treatment.
However, because the low dose of methapyri-
lene administered for 7 days resulted in the
appearance of hepatotoxicity (Hamadeh et al.
2002), it was difﬁcult to identify gene changes
to be excluded that are due to the pharmaco-
logic effect of methapyrilene administration.
Although many of the gene changes induced
by methapyrilene are involved in the mecha-
nism of methapyrilene-mediated hepatotoxic-
ity, it is quite likely that some of the genes and
pathways identified are not related to the
development of toxicity.
Thus, to facilitate the identification of
toxicity-related genes, we compared gene
changes in a nontarget tissue for toxicity—the
kidney—with those of the target organ of
methapyrilene toxicity—the liver—in addition
to analyzing gene expression changes across
dose level and number of doses. To accomplish
this goal, we analyzed global gene expression
changes using microarrays from RNA isolated
from kidneys obtained from the Hamadeh
et al. (2002) study, in addition to reanalyzing
the liver RNA generated from this same study.
The combination of all three factors in this
experiment (dose level, number of doses, and
tissue) has provided us with a greater ability
to focus on the gene expression changes
that appear to be due to or in response to
methapyrilene-induced liver injury.
Materials and Methods
Animals and treatment. Animal handling and
treatment have been described in detail previ-
ously (Hamadeh et al. 2002). In brief, we
dosed male Sprague-Dawley (Charles River
Laboratories, Kingston, NY) rats for one,
three, or seven daily doses by gavage with vehi-
cle (water), 10 mg/kg/day methapyrilene, or
100 mg/kg/day methapyrilene (n = 4 rats per
dose group). Twenty-four hours after the last
dose, livers and kidneys were collected from
animals euthanized by CO2 asphyxiation.
Cross-sections of the left liver lobe and the left
kidney were collected in 10% neutral-buffered
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BACKGROUND: Toxicogenomics experiments often reveal thousands of transcript alterations that are
related to multiple processes, making it difﬁcult to identify key gene changes that are related to the
toxicity of interest.
OBJECTIVES: The objective of this study was to compare gene expression changes in a nontarget
tissue to the target tissue for toxicity to help identify toxicity-related genes.
METHODS: Male rats were given the hepatotoxicant methapyrilene at two dose levels, with livers
and kidneys removed 24 hr after one, three, and seven doses for gene expression analysis. To iden-
tify gene changes likely to be related to toxicity, we analyzed genes on the basis of their temporal
pattern of change using a program developed at the National Institute of Environmental Health
Sciences, termed “EPIG” (extracting gene expression patterns and identifying co-expressed genes).
RESULTS: High-dose methapyrilene elicited hepatic damage that increased in severity with the num-
ber of doses, whereas no treatment-related lesions were observed in the kidney. High-dose
methapyrilene elicited thousands of gene changes in the liver at each time point, whereas many
fewer gene changes were observed in the kidney. EPIG analysis identiﬁed patterns of gene expres-
sion correlated to the observed toxicity, including genes associated with endoplasmic reticulum
stress and the unfolded protein response.
CONCLUSIONS: By factoring in dose level, number of doses, and tissue into the analysis of gene
expression elicited by methapyrilene, we were able to identify genes likely to not be implicated in
toxicity, thereby allowing us to focus on a subset of genes to identify toxicity-related processes.
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http://dx.doi.org/ [Online 17 January 2007]formalin for histopathologic evaluation. The
remaining left liver lobe and left kidney were
minced and snap frozen in liquid nitrogen
within several minutes after euthanasia for
RNA isolation. Animals were treated
humanely and with regard for the alleviation of
suffering in accordance with the guidelines
established in the Public Health Service Policy
on Humane Care and Use of Laboratory
Animals (National Institutes of Health 2002).
Histopathology. Representative sections of
liver and kidney from all animals were
processed, embedded in parafﬁn, sectioned in
5-µm slices, and stained with hematoxylin
and eosin. Microscopic histopathologic evalu-
ations of the tissue sections were conducted
by a veterinary pathologist and reviewed by a
team of veterinary pathologists. Results from
histopathologic analysis of the liver sections
were reported in an earlier article (Hamadeh
et al. 2002).
RNA isolation. Isolation of liver RNA has
been described previously (Hamadeh et al.
2002). We isolated and quantitated total
RNA from kidney using the same protocol.
For both liver and kidney samples, we pooled
equal amounts of RNA from each of the four
animals per treatment or control group for
gene expression analysis.
Microarray analysis. We prepared cRNA
targets from 500 ng total RNA by following
the protocol outlined in the Agilent Low
RNA Input Fluorescent Linear Ampliﬁcation
Kit (Agilent Technologies, Santa Clara, CA).
The cRNA targets from each treatment
group’s pooled sample were hybridized to the
Agilent Rat Oligo Microarray (G4130A,
22,575 probes representing more than 20,000
genes and expressed sequence tags; Agilent
Technologies) in quadruplicate, with fluor
reversals, against the time-matched pooled
control sample according to Agilent’s
Oligonucleotide Microarray Hybridization
Protocol (Agilent Technologies 2007).
Fluorescent intensities were measured with the
Agilent Scanner and analyzed using Array Suite
Software (version 7.1; Agilent Technologies).
The resulting image and data ﬁles were loaded
into Rosetta Resolver (version 5.1; Rosetta
Biosoftware, Seattle, WA) for further analysis.
Data from each treatment group’s four individ-
ual chips were combined in Resolver to achieve
average fold changes and p-values according to
Resolver’s Error Model (Weng et al. 2006).
Differentially expressed genes identified by
Resolver’s Error Model for each group (based
on the four combined chips) were those with a
p-value < 0.001, fluorescent intensity for at
least one channel > 500, and absolute fold
change > 1.2. In addition, we used an analyti-
cal program developed at the National
Institute of Environmental Health Sciences
(NIEHS), EPIG (extracting gene expression
patterns and identifying co-expressed genes), to
identify patterns of gene expression that
differed between the liver and kidney (Zhou
et al. 2006). EPIG identiﬁed genes belonging
to a pattern according to the following criteria:
signal-to-noise ratio > 3, correlation > 0.85,
with a minimum of seven genes required to
make up a pattern.
The microarray data generated for this
study have been deposited in the National
Center for Biotechnology Information’s Gene
Expression Omnibus (GEO, http://www.
ncbi.nlm.nih.gov/geo/; Edgar et al. 2002) and
are accessible through GEO Series accession
number GSE5381.
Results
Histopathology. A detailed histopathologic
analysis of the rat livers from methapyrilene
administration has been described previously
(Hamadeh et al. 2002). Briefly summarized,
high-dose methapyrilene (100 mg/kg) elicited
hepatocellular necrosis, periportal lipid vac-
uolization, and biliary hyperplasia that
increased in incidence and severity from one
to seven doses. Low-dose methapyrilene
(10 mg/kg) administration resulted in mini-
mal hepatocyte necrosis after only seven doses.
See Hamadeh et al. (2002) for representative
images of liver histology after methapyrilene
administration. No treatment-related observa-
tions were noted in the kidney after metha-
pyrilene administration [see Figure 1 in
Supplemental Material for representative
images of kidney histology (http://www.
ehponline.org/docs/2007/9396/suppl.pdf)],
justifying the use of the kidney as a nontarget
tissue for toxicity.
Differential gene expression. To compare
differential gene expression in the liver and
kidney after methapyrilene treatment, RNA
from livers and kidneys were hybridized to
the Agilent rat oligonucleotide microarray
chip. The liver RNA, which was previously
analyzed with an in-house cDNA chip made
at the NIEHS as previously reported by
Hamadeh et al. (2002), was reanalyzed on the
Agilent rat oligonucleotide chip for two rea-
sons. First, using the same platform to analyze
gene expression changes in the liver and the
kidney facilitates the comparison of the two
tissues (Weis and Consortium 2005). Second,
the Agilent oligonucleotide chips contain
greater content and have better annotation
than our previous cDNA chips.
We used the Rosetta Resolver Error Model
(Weng et al. 2006) to identify differentially
expressed genes in each tissue at each time
point for the two different doses of methapyri-
lene (Table 1). High-dose (100 mg/kg/day)
methapyrilene administration resulted in the
differential expression of thousands of genes in
the liver at each time point, increasing from
1,736 genes after one dose to 3,123 genes after
seven daily doses. A total of 4,258 genes in the
liver were identified as being differentially
expressed by high-dose methapyrilene adminis-
tration for at least one time point, with over
700 genes differentially expressed at each time
point. Of those genes found to be differentially
expressed in the liver at each time point, more
than 95% were either up-regulated or down-
regulated at all three time points. Low-dose
(10 mg/kg/day) methapyrilene administration
resulted in the differential expression of fewer
genes in the liver, with the greatest number of
differentially expressed genes observed after
only one dose (715 genes). Although a total of
1,245 genes were differentially expressed in the
liver after low-dose methapyrilene administra-
tion for at least one time point, only 2 genes
were consistently differentially expressed
(down-regulated) across all three time points. 
Toxicogenomics of methapyrilene hepatotoxicity
Environmental Health Perspectives • VOLUME 115 | NUMBER 4 | April 2007 573
Table 1. Number of differentially expressed genes in liver and kidney after methapyrilene administration.
Up- Down- Up Down
Group Genes regulated regulated Union intersection intersection
Liver
100 mg/kg, 1 day 1,736 1,074 662
100 mg/kg, 3 days 2,216 1,504 712 4,258 554 191
100 mg/kg, 7 days 3,123 2,153 970
10 mg/kg, 1 day 715 333 382
10 mg/kg, 3 days 349 77 272 1,245 0 2
10 mg/kg, 7 days 414 229 185
Kidney
100 mg/kg, 1 day 267 170 97
100 mg/kg, 3 days 183 54 129 544 2 6
100 mg/kg, 7 days 226 125 101
10 mg/kg, 1 day 202 133 69
10 mg/kg, 3 days 129 29 100 385 1 1
10 mg/kg, 7 days 143 71 72
Animals were treated with one, three, or seven daily doses of methapyrilene (10 or 100 mg/kg/day). Differential gene
expression in liver and kidney were measured 24 hr after the last dose using the Agilent rat chip. Differentially expressed
genes were identiﬁed using the Rosetta Resolver Error Model using the following criteria: intensity > 500 in at least one
channel, absolute fold change > 1.2, and p < 0.001. The second column lists the total number of genes differentially
expressed in the given treatment group; the third and fourth columns list the number of genes up-regulated and down-
regulated, respectively, in each treatment group. The “Union” column lists the union of all the differentially expressed
genes across all three treatment periods for each tissue and dose group. The last two columns list the intersection of the
up-regulated and down-regulated genes, respectively, across all three treatment periods for each tissue and dose group.Compared with the differential gene
expression observed in the liver, methapyrilene
administration resulted in only 200 genes
being differentially expressed in the kidney,
ranging from 129 genes after three low doses
to 267 after one high dose (Table 1). A total
of 544 genes were identiﬁed as being differen-
tially expressed in at least one time point in
kidneys from animals treated with high-dose
methapyrilene, whereas only 385 genes were
identiﬁed as being differentially expressed in at
least one time point in kidneys from animals
treated with low-dose methapyrilene. Similar
to what was observed in livers from low-dose
animals, very few genes were consistently
differentially expressed across all time points
for each dose group, with only 8 and 2 genes
consistently altered in high-dose– or low-
dose–treated animals, respectively.
Liver and kidney gene expression compari-
son. To identify gene changes specifically
related to the hepatotoxicity of methapyrilene,
we compared gene expression alterations in the
liver with those in the kidney, under the
assumption that genes with similar expression
patterns in both the liver and kidney are not
likely to be related to the toxic actions of
methapyrilene.  We make this assumption
because no treatment-related pathologic lesions
were observed in the kidney after methapyrilene
administration. Because methapyrilene is bio-
activated to toxic metabolites via cytochromes
P450 in the liver (Ratra et al. 1998a) and
undergoes extensive enterohepatic circulation
(Ratra et al. 2000), we reasoned that biologi-
cally significant gene expression alterations
would be of smaller magnitude in the kidney
than in the liver. This was the case with smaller
numbers of differentially expressed genes
detected in the kidney compared with the liver
(Table 1). Accordingly, using strict fold-change
or p-value cutoffs might not have the required
sensitivity to detect important gene changes in
the nontarget tissue. However, because gene
expression data were gathered from multiple
time points after methapyrilene administration,
it was possible to use the gene expression pro-
files over time to identify genes regulated in
common and differentially in the two tissues.
Thus, by examining the temporal proﬁles that
genes display in each tissue, we can ascribe gene
expression alterations to speciﬁc effects, such as
those related to toxicity or the pharmacologic
actions of methapyrilene. 
We used EPIG to examine the temporal
proﬁles of gene expression in the liver and kid-
ney after methapyrilene administration. Using
the parameters described in “Material and
Methods,” EPIG identiﬁed 17 distinct proﬁles
of gene expression elicited by methapyrilene
administration, which contained a total of
1,962 genes [see Supplemental Material for all
EPIG patterns (http://www.ehponline.org/
docs/2007/9396/suppl.pdf)]. Agglomerative,
hierarchical clustering (cosine correlation with
average linkage) was performed on all samples
using the 1,962 genes selected by EPIG
(Figure 1). The high-dose liver samples clus-
tered together primarily because of the greatest
changes in differential expression observed in
these treatment groups. The low-dose liver
sample at 7 days also clusters with the high-
dose liver samples, which is consistent with the
onset of hepatic damage observed after seven
doses of 10 mg/kg methapyrilene (Hamadeh
et al. 2002). The remaining low-dose liver
samples and the kidney samples tend to cluster
based upon the number of doses the animals
received. From this clustering it is apparent
that the liver samples cluster primarily on
the basis of the degree of hepatotoxicity elicited
by methapyrilene (i.e., a dose-dependent
response), whereas the kidney samples cluster
on the number of doses administered, regard-
less of dose. The greatest number of genes
selected by EPIG belonged to two different
proﬁles. One of these proﬁles (pattern no. 6)
consisted of 956 genes up-regulated by
methapyrilene in a dose- and time-dependent
manner in the liver only, with no change in
expression levels in the kidney (Figure 2A).
Genes that were identiﬁed in pattern no. 6 are
hypothesized to be involved in methapyrilene
toxicity, either in eliciting toxicity or in
response to toxicity, as the pattern mirrors very
nicely the incidence and severity of histopatho-
logic lesions observed in the liver (Hamadeh
et al. 2002). Genes in this pattern are highly
enriched for protein synthesis (53 genes encod-
ing ribosomal proteins and 10 genes involved
with the E48S initiation complex) and cell
death/apoptosis (19 genes), which are indica-
tive of the cell stress response, repair response,
and structural remodeling that have been iden-
tified previously (Hamadeh et al. 2002;
Waring et al. 2004). The other proﬁle (pattern
no. 4) was just the opposite: 487 genes down-
regulated in a dose- and time-dependent man-
ner in the liver only, again with no change in
the kidney (Figure 2B). Genes in this pattern
are highly enriched for cytochromes P450
(23 genes), lipid metabolism (38 genes),
steroid metabolism (13 genes), and fatty acid
β-oxidation (5 genes). As with the genes in pat-
tern no. 6, these biological pathways and
processes were identified in previous reports
analyzing gene expression changes after
methapyrilene exposure (Hamadeh et al. 2002;
Waring et al. 2004). In addition to conﬁrming
earlier results, our analysis of gene expression
changes after methapyrilene administration
revealed that methapyrilene induces an endo-
plasmic reticulum (ER) stress response in the
liver. Twenty-nine genes involved in the ER
stress response and/or unfolded protein bind-
ing were identiﬁed in the hepatotoxicity pat-
terns (nos. 1, 4, 6), including genes such as
eukaryotic translation initiation factor 2,
Auman et al.
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Figure 1. Hierarchical clustering of tissue samples after methapyrilene administration. Agglomerative hier-
archical cluster (cosine correlation with average linkage) and heat map of liver and kidney samples after
methapyrilene administration for one to seven doses across the 1,962 genes identiﬁed as being differen-
tially expressed by EPIG. The liver samples cluster together primarily on the basis of the severity of toxicity
elicited by methapyrilene, whereas the kidney samples cluster primarily on the basis of the number of
doses received, regardless of dose level. Each sample listed contains the average gene expression value
for four replicates. The heat map displays the average gene expression ratio of treated samples compared
with time-matched control. Red indicates genes that are up-regulated after methapyrilene treatment;
green indicates genes that are down-regulated after methapyrilene treatment; and black indicates no
change in gene expression between methapyrilene-treated animals and vehicle-treated animals. 
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Log (ratio)subunit 1 alpha (Eif2s1), heat shock 70 kDa
protein 5 (Hspa5), and activating transcription
factor 4 (Atf4). Extending these results to
include all differentially expressed genes,
regardless of EPIG pattern, we found that
methapyrilene elicits a dose-dependent increase
in the number and fold change of differentially
expressed genes involved in the ER stress
response and/or unfolded protein binding in
the liver only, from 16 differentially expressed
genes after seven low doses to 42 differentially
expressed genes after one high dose up to
64 differentially expressed genes after seven
high doses of methapyrilene [Figure 3; Table 1
in Supplemental Material (http://www.
ehponline.org/docs/2007/9396/suppl.pdf)].
Although many of the gene expression
alterations identiﬁed by EPIG conﬁrmed those
that were previously published, the real strength
of this analysis is the identification of those
genes and processes that may be related to
events other than methapyrilene-mediated
hepatotoxicity. EPIG identiﬁed gene changes
associated with a single administration of
methapyrilene that were dose independent (pat-
tern nos. 10, 13, and 16). The 89 genes in these
three patterns (Figure 4) include genes involved
in the acute stress response, such as heat shock
protein 70 and α-2 macroglobulin. Because
these genes are induced or repressed only after a
single administration, regardless of dose, they
appear to indicate a stress-related response due
to methapyrilene administration. EPIG also
identiﬁed genes with similar expression proﬁles
in both the liver and kidney, which we consider
less likely to be involved in hepatotoxicity.
However, it is possible that adaptive mecha-
nisms are present in the kidney that prevent
toxicity [see EPIG pattern nos. 7, 8, 14, and 17
in Supplemental Material (http://www.ehpon-
line.org/docs/2007/9396/suppl.pdf)]. The
genes in these four separate patterns (a total of
264 genes) are involved in processes such as
glucose homeostasis, protein transport and
localization, and transcriptional regulation.
Finally, EPIG identiﬁed genes speciﬁcally dif-
ferentially expressed in the kidney rather than
the liver. Pattern no. 9 [Supplemental Material
(http://www.ehponline.org/docs/2007/9396/
suppl.pdf)] contains genes that are up-regulated
in the kidney after methapyrilene administra-
tion but down-regulated slightly in the liver,
including several metallothionein genes and
multidrug resistance protein 3.
Discussion
The main goal of many toxicogenomics
experiments is to use global gene expression
proﬁling to gain insight into the mechanism
underlying the organ damage elicited by the
studied toxicant or environmental stressor. As
most toxicogenomics experiments produce
hundreds to thousands of gene expression
changes resulting from toxicant exposure,
trying to identify those gene changes that
correspond to the cellular events involved in
toxicity is quite daunting. Furthermore, the
biological meaning underlying the observed
gene expression changes is confounded by the
multitude of tissue responses that occur with
exposure to environmental agents, including
but not limited to pharmacologic responses,
nonspecific acute stress responses, toxic
responses, adaptive responses, and recovery
responses. Proper study design can help reduce
the complexity of biological interpretation of
Toxicogenomics of methapyrilene hepatotoxicity
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Figure 3. Hierarchical clustering of genes involved in ER stress and the unfolded protein response.
Methapyrilene elicited up-regulation of numerous genes associated with ER stress and the unfolded protein
response primarily in the high-dose liver only. Many of these genes are key regulators of ER stress, such
as Hspa5 and Eif2s1, whereas others, such as Atf4 and Gadd34/Myd116, are transcripts downstream of the
unfolded protein response. Using Gene Ontology (http://www.geneontology.org/GO.annotation.shtml)
annotation for ER stress or unfolded protein binding, 75 genes were identified that were differentially
expressed in high-dose liver in at least one time point. Table 1 in Supplemental Material
(http://www.ehponline.org/docs/2007/9396/suppl.pdf)  lists all 75 genes and their relative fold change after
methapyrilene administration.
Figure 2. Gene expression patterns correlated to methapyrilene-mediated hepatotoxicity. EPIG identiﬁed
patterns that contain genes with expression values that correlate with methapyrilene-induced hepatotoxic-
ity. (A) EPIG pattern no. 6 contains 956 genes whose expression ratios increase with the number of high
methapyrilene doses in the liver but no changes in the kidney. (B) EPIG pattern no. 4 contains 487 genes for
which expression ratios decrease with the number of high methapyrilene doses in the liver but no changes
in the kidney. Each point on the graph represents the average expression value of the top 5 genes in the
pattern for each microarray performed. See Zhou et al. (2006) for a more detailed description of EPIG.
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incorporate multiple doses and multiple time
points into the study design (Amin et al.
2004; Bulera et al. 2001; Hamadeh et al.
2004, 2002; Heijne et al. 2003; Heinloth
et al. 2004; Kier et al. 2004; Lühe et al. 2003;
Ruepp et al. 2002), but based on results from
this study, we also recommend obtaining gene
expression data from a nontarget tissue, in
addition to using multiple dose levels and time
points, for the purpose of clarifying the bio-
logical relevance of the observed expression
changes in the target tissue for toxicity.
We chose to use the kidney as the non-
target tissue for methapyrilene hepatotoxicity
primarily because methapyrilene administra-
tion did not induce any pathologic lesions in
the kidney. Once an appropriate nontarget tis-
sue had been selected, the question that
remained was how to best use the information
gained from analyzing gene expression changes
in the nontarget tissue. Not surprisingly,
methapyrilene administration resulted in rela-
tively few gene expression changes at each time
point in the kidney compared with the liver
(Table 1) when using fold-change and p-value
criteria to establish significance. However,
examining differential gene expression at each
time point in isolation does not take advantage
of the study design employed in this experi-
ment, namely, two different doses and three
time periods of methapyrilene exposure.
We used the analytical program EPIG to
identify signiﬁcant changes in gene expression
on the basis of their pattern of expression over
time, including both doses and the two tissues.
EPIG identiﬁed biologically signiﬁcant genes
by using each gene’s signal magnitude and sig-
nal-to-noise ratio to categorize them into pat-
terns of expression in an unsupervised manner
(Zhou et al. 2006; Chou JW, Zhou T, Paules
RS, Kaufman WK, Bushel PR, unpublished
data), based on the assumption that genes
within the same pattern are co-expressed
because they have a regulator in common or
they are involved in the cellular events that the
pattern describes. The advantages of using the
temporal patterns of gene expression to iden-
tify biologically relevant genes are severalfold.
First, this method of analyzing gene expression
will help exclude false positives by including
only genes in patterns that have similar proﬁles
to other genes. Second, it is more straightfor-
ward to correlate patterns of gene expression
with the observed histologic changes that occur
over time. Third, it is highly likely that biologi-
cally relevant genes that are changed because of
a perturbed cellular process will have similar
proﬁles of expression. Fourth, for this experi-
ment it is not necessary to have strict fold-
change or p-value cutoffs, so that a wider range
of gene changes can be identiﬁed. This is par-
ticularly useful in this experiment because of
the different sensitivities of the two tissues to
methapyrilene. The liver is highly sensitive to
methapyrilene-mediated toxicity, in part
because of the considerable enterohepatic cir-
culation of methapyrilene and its metabolites
(Ratra et al. 2000). Consequently, the kidney
is not exposed to the same levels of methapyri-
lene as the liver. In addition, the oral route of
administration will also ensure that the liver is
exposed to higher levels of methapyrilene than
the kidney because of the ﬁrst-pass effect.
The results provided by EPIG analysis of
the gene expression patterns conﬁrms the gene
changes identiﬁed in the previously published
reports (Hamadeh et al. 2002; Waring et al.
2004). However, our analysis differs in that we
have identiﬁed select groups of genes that we
can reasonably ascribe to different physiologic
or pathologic processes that occur because of
methapyrilene administration. The greatest
number of gene expression alterations occurs in
two patterns (nos. 4 and 6), which show
changes in expression in a dose- and tissue-
speciﬁc manner; signiﬁcant changes occurred
in the liver but not in the kidney. This is espe-
cially encouraging in that it implies that the
major biological event, namely, hepatotoxicity,
is responsible for the majority of the observed
gene changes, as these two patterns correlate
well with the development of hepatotoxicity
elicited by methapyrilene. Our analysis con-
ﬁrms that methapyrilene-mediated hepatotoxi-
city is accompanied by induction of genes
involved in protein translation, structural
remodeling, cell death/apoptosis, and the
repression of several metabolic processes
including lipid metabolism, steroid metabo-
lism, and fatty acid β-oxidation.
In addition to the repression of genes
involved in cellular metabolism, high-dose
methapyrilene administration resulted in the
down-regulation of numerous cytochrome
P450 enzymes, as previously reported
(Hamadeh et al. 2002; Waring et al. 2004;
Wrighton et al. 1991). Our analysis indicates
that the concomitant down-regulation of the
nuclear receptors that regulate cellular and
xenobiotic metabolism–related gene expres-
sion may be the underlying cause for the
observed repressed pathways. Farnesoid X
receptor [FXR/Nr1h4; GenBank accession no.
NM_021745 (http://www.ncbi.nlm.nih.gov/
Genbank/)] and pregnane X receptor (PXR/
Nr1i2; GenBank accession no.  NM_052980),
which have been shown to maintain choles-
terol and lipid homeostasis (Guo et al. 2003;
Lambert et al. 2003), are down-regulated in
high-dose livers only (pattern nos. 4 and 1,
respectively). Coupled with the down-regula-
tion of PXR, methapyrilene also induced a
liver-dependent down-regulation of the consti-
tutive androstane receptor (CAR/Nr1i3;
GenBank accession no.  NM_022941) and
retinoid X receptor alpha (RXRa; GenBank
accession no. NM_012805), possibly account-
ing for the repression of numerous xenobiotic-
metabolizing enzymes (Beigneux et al. 2002;
Wei et al. 2002). Besides their roles in differ-
entially regulating the expression of genes
involved in various metabolic functions, the
repression of these receptors/transcription
factors may explain, at least in part, the
Auman et al.
576 VOLUME 115 | NUMBER 4 | April 2007 • Environmental Health Perspectives
Figure 4. Gene expression patterns indicative of an acute response to methapyrilene administration. EPIG identiﬁed several expression patterns where the great-
est change in gene expression was observed after a single dose. (A) EPIG pattern no. 10 (20 genes) with a dose-independent down-regulation of genes after a
single dose of methapyrilene in the liver only. (B) EPIG pattern no. 16 (25 genes) with a dose-independent up-regulation of genes after a single dose of methapyri-
lene in the liver only. (C) EPIG pattern no. 13 (45 genes) with a dose-independent up-regulation of genes after a single dose of methapyrilene. Genes in pattern
no. 13 exhibit similar changes in liver and kidney but with a higher magnitude of change in the liver.
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down-regulation of PXR may contribute to
the hepatotoxicity of methapyrilene, as the lig-
and-induced activation of PXR serves to pro-
tect against bile acid toxicity resulting from
several hepatotoxicants (Staudinger et al.
2001), whereas the resistance to bile acid toxi-
city is lost in mice lacking PXR (Xie et al.
2000). Additionally, PXR and CAR work in
concert to protect against cholestatic injury
induced by bile duct ligation (Stedman et al.
2005). The down-regulation of PXR and
CAR, along with FXR (Guo et al. 2003),
would make the liver more susceptible to bile
acid toxicity, which, coupled with the biliary
hyperplasia, may exacerbate the hepatotoxic
effects of methapyrilene administration.
Our gene expression analysis also suggests
another novel aspect underlying metha-
pyrilene-mediated hepatotoxicity, namely,
ER stress resulting from the unfolded protein
response [reviewed by Boyce and Yuan
(2006)]. ER stress and the unfolded protein
response have been shown to be involved in
hepatotoxicity resulting from acetaminophen
(Macanas-Pirard et al. 2005), cyclohexamide
(Ito et al. 2006), ethanol (Ji and Kaplowitz
2003), and hepatitis C virus (Benali-Furet
et al. 2005). The unfolded protein response is
activated by the influx of unfolded proteins
into the ER lumen that exceed the processing
capacity of the ER to restore ER homeostasis
[reviewed by Patil and Walter (2001);
Schroder and Kaufman (2005)]. Several key
chaperones are up-regulated only in the liver
after methapyrilene administration, including
heat shock 70 kDa proteins 5 and 9a and sev-
eral genes in the DnaJ (Hsp40) homolog fam-
ily [Figure 4; Table 1 in Supplemental
Material (http://www.ehponline.org/docs/
2007/9396/suppl.pdf)]. Furthermore, ER
stress-inducible genes,  such as Atf4, Gadd34/
Myd116, and Ddit3/CHOP, are up-regulated
in the liver after high-dose methapyrilene
administration. Even though the unfolded pro-
tein response is activated to restore ER homeo-
stasis, if the stress is too strong or prolonged,
ER stress can lead to cellular apoptosis
[reviewed by Boyce and Yuan (2006); Patil and
Walter (2001); Schroder and Kaufman
(2005)]. Our results also suggest that the ER
stress elicited by methapyrilene leads to hepato-
cellular apoptosis/cell death, as evidenced by
the up-regulation of genes involved in apopto-
sis/cell death, including caspase 9, caspase 11,
caspase 12, and BCL-associated X protein. The
exact mechanism through which methapyri-
lene induces ER stress and the unfolded pro-
tein response is currently unknown, but several
possibilities exist. Oxidative stress, which may
induce or be a consequence of ER stress
(Cullinan and Diehl 2006), has been reported
to be associated with methapyrilene hepato-
toxicity (Ratra et al. 1998b), although other
reports suggest that oxidative stress is not
involved in methapyrilene-mediated hepato-
toxicity (Ratra et al. 2000). Additionally, the
unfolded protein response may be activated by
the methapyrilene-mediated perturbations in
cellular lipid metabolism, as excess saturated
fatty acids have been shown to alter ER home-
ostasis in liver cells, resulting in ER stress and
apoptosis (Wei et al. 2006). It is also possible
that biliary damage associated with methapyri-
lene hepatotoxicity induces ER stress, as bile
acids have been shown to elicit this stress
(Bernstein et al. 1999; Payne et al. 2005).
By examining the expression profiles in
both the liver and kidney (at various doses and
times), we have also been able to identify
genes, biological processes, and pathways
unlikely to be involved in methapyrilene
hepatotoxicity. EPIG identiﬁed three proﬁles
that are indicative of an acute response to
methapyrilene administration, that is, either
induction or repression after a single dose of
methapyrilene only. One might consider these
genes to be involved in hepatotoxicity; how-
ever, all three of the proﬁles indicate that the
gene expression alterations are independent of
dose in the liver, and one proﬁle shows similar
changes in the kidney as well. Thus, these
genes and pathways can be ruled out in our
analysis of hepatotoxicity, as they likely repre-
sent a generalized acute stress response to
methapyrilene administration. For example,
several genes involved in glucose homeostasis
are altered after a single dose in both the liver
and kidney. This implies that methapyrilene
administration transiently alters glucose han-
dling and production; however, the tissues are
able to resume normal glucose homeostasis by
the third dose of methapyrilene.
Our analysis of the gene expression data
has also changed the interpretation of some of
the processes that have previously been
reported to be involved in methapyrilene-
mediated hepatotoxicity. Methapyrilene was
reported to elicit oxidative stress in the liver, as
evidenced by the up-regulation of genes
involved in glutathione production and other
genes involved in the response to oxidative
stress (Waring et al. 2004). However, most of
these genes were not selected by EPIG as
belonging to any of the identified patterns,
possibly because the selection of these genes is
differentially expressed at a single time point in
the previous analysis. If that were the case, then
they would not be identiﬁed in EPIG as being
biologically relevant, under the presupposition
that biologically relevant gene expression alter-
ations show concordant patterns with other
important genes. As an example, many glu-
tathione S-transferases are up-regulated in the
liver after only seven high doses of methapyri-
lene, but only glutathione S-transferase a5 was
identiﬁed by EPIG in a toxicity-related pattern
(pattern no. 6). Rather than being directly
related methapyrilene-mediated hepatotoxicity,
the altered expression of genes involved in glu-
tathione production and oxidative stress may
be secondary to the accumulation of reactive
biliary metabolites (Ratra et al. 2000). In addi-
tion, Waring et al.  (2004) observed alterations
in genes involved in the sterol/retinol pathway;
however, EPIG did not identify these genes as
belonging to a pattern, again suggesting that
these gene alterations are not directly related to
hepatotoxicity.
In conclusion, our data show that
comparing gene expression changes between
target and nontarget tissues for toxicity can
help clarify the biological interpretation of
identiﬁed gene changes. Additionally, examin-
ing gene changes across multiple time points
and multiple doses is more advantageous than
comparing gene changes at each time point in
isolation, which has the potential of missing
biologically relevant genes. By examining gene
expression across tissue, dose level, and num-
ber of doses, we were able to ﬁlter out genes
that are in common between target and non-
target tissue, as these reﬂect nonspeciﬁc prop-
erties of the compound administration.
Furthermore, gene changes that appear to be
due to a nonspeciﬁc stress response can also be
ﬁltered out, thus leaving a more focused set of
genes to concentrate on in our understanding
of the cellular events that occur during and
after compound-mediated toxicity.
REFERENCES
Agilent Technologies. 2007. Oligonucleotide Microarray
Hybridization Protocol. Available: http://www.chem.agilent.
com/scripts/generic.asp?lpage=14919&indcol=Y&prodcol=Y
[accessed 28 February 2007].
Amin RP, Vickers AE, Sistare F, Thompson KL, Roman RJ, Lawton
M, et al. 2004. Identiﬁcation of putative gene based markers
of renal toxicity. Environ Health Perspect 112:465–479.
Beekman JM, Boess F, Hildebrand H, Kalkuhl A, Suter L. 2006.
Gene expression analysis of the hepatotoxicant methapyri-
lene in primary rat hepatocytes: an interlaboratory study.
Environ Health Perspect 114:92–99.
Beigneux AP, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR.
2002. Reduction in cytochrome P-450 enzyme expression is
associated with repression of CAR (constitutive androstane
receptor) and PXR (pregnane X receptor) in mouse liver
during the acute phase response. Biochem Biophys Res
Commun 293:145–149.
Benali-Furet NL, Chami M, Houel L, De Giorgi F, Vernejoul F,
Lagorce D, et al. 2005. Hepatitis C virus core triggers apop-
tosis in liver cells by inducing ER stress and ER calcium
depletion. Oncogene 24:4921–4933.
Bernstein H, Payne CM, Bernstein C, Schneider J, Beard SE,
Crowley CL. 1999. Activation of the promoters of genes
associated with DNA damage, oxidative stress, ER stress
and protein malfolding by the bile salt, deoxycholate.
Toxicol Lett 108:37–46.
Boorman GA, Blackshear PE, Parker JS, Lobenhofer EK,
Malarkey DE, Vallant MK, et al. 2005. Hepatic gene expres-
sion changes throughout the day in the Fischer rat: implica-
tions for toxicogenomic experiments. Toxicol Sci
86:185–193.
Boyce M, Yuan J. 2006. Cellular response to endoplasmic reticu-
lum stress: a matter of life or death. Cell Death Differ
13:363–373.
Bulera SJ, Eddy SM, Ferguson E, Jatkoe TA, Reindel JF, Bleavins
MR, et al. 2001. RNA expression in the early characteriza-
tion of hepatotoxicants in Wistar rats by high-density DNA
microarrays. Hepatology 33:1239–1258.
Toxicogenomics of methapyrilene hepatotoxicity
Environmental Health Perspectives • VOLUME 115 | NUMBER 4 | April 2007 577Auman et al.
578 VOLUME 115 | NUMBER 4 | April 2007 • Environmental Health Perspectives
Cullinan SB, Diehl JA. 2006. Coordination of ER and oxidative
stress signaling: the PERK/Nrf2 signaling pathway. Int J
Biochem Cell Biol 38:317–332.
Edgar R, Domrachev M, Lash AE. 2002. Gene Expression
Omnibus: NCBI gene expression and hybridization array
data repository. Nucl Acids Res 30:207–210.
Guo GL, Lambert G, Negishi M, Ward JM, Brewer H Jr,
Kliewer SA, et al. 2003. Complementary roles of farnesoid X
receptor, pregnane X receptor, and constitutive androstane
receptor in protection against bile acid toxicity. J Biol Chem
278:45062–45071.
Hamadeh HK, Jayadev S, Gaillard ET, Huang Q, Stoll R,
Blanchard K, et al. 2004. Integration of clinical and gene
expression endpoints to explore furan-mediated hepato-
toxicity. Mutat Res 549:169–183.
Hamadeh HK, Knight BL, Haugen AC, Sieber S, Amin RP,
Bushel PR, et al. 2002. Methapyrilene toxicity: anchorage
of pathologic observations to gene expression alterations.
Toxicol Pathol 30:470–482.
Heijne WHM, Stierum RH, Slijper M, van Bladeren PJ, van
Ommen B. 2003. Toxicogenomics of bromobenzene hepa-
totoxicity: a combined transcriptomics and proteomics
approach. Biochem Pharmacol 65:857–875.
Heinloth AN, Irwin RD, Boorman GA, Nettesheim P, Fannin RD,
Sieber SO, et al. 2004. Gene expression proﬁling of rat liv-
ers reveals indicators of potential adverse effects. Toxicol
Sci 80:193–202.
Ito K, Kiyosawa N, Kumagai K, Manabe S, Matsunuma N, Yamoto
T. 2006. Molecular mechanism investigation of cyclo-
heximide-induced hepatocyte apoptosis in rat livers by mor-
phological and microarray analysis. Toxicology 219:175–186.
Ji C, Kaplowitz N. 2003. Betaine decreases hyperhomocys-
teinemia, endoplasmic reticulum stress, and liver injury in
alcohol-fed mice. Gastroenterology 124:1488–1499.
Kier LD, Neft R, Tang L, Suizu R, Cook T, Onsurez K, et al. 2004.
Applications of microarrays with toxicologically relevant
genes (tox genes) for the evaluation of chemical toxicants
in Sprague Dawley rats in vivo and human hepatocytes in
vitro. Mutat Res 549:101–113.
Kita Y, Shiozawa M, Jin W, Majewski RR, Besharsed JC, Green
AS, et al. 2002. Implications of circadian gene expression
in kidney, liver and the effects of fasting on pharmaco-
genomic studies. Pharmacogenetics 12:55–65.
Lambert G, Amar MJA, Guo G, Brewer HB, Jr., Gonzalez FJ,
Sinal CJ. 2003. The farnesoid X-receptor is an essential
regulator of cholesterol homeostasis. J Biol Chem
278:2563–2570.
Lijinsky W, Reuber MD, Blackwell BN. 1980. Liver tumors
induced in rats by oral administration of the antihistaminic
methapyrilene hydrochloride. Science 15:817–819.
Lühe A, Hildebrand H, Bach U, Dingermann T, Ahr H-J. 2003. A
new approach to studying ochratoxin A (OTA)-induced
nephrotoxicity: expression profiling in vivo and in vitro
employing cDNA microarrays. Toxicol Sci 73:315–328.
Macanas-Pirard P, Yaacob N-S, Lee PC, Holder JC, Hinton RH,
Kass GEN. 2005. Glycogen synthase kinase-3 mediates
acetaminophen-induced apoptosis in human hepatoma
cells. J Pharmacol Exp Ther 313:780–789.
National Institutes of Health. 2002. Public Health Service Policy
on Humane Care and Use of Laboratory Animals. Bethesda,
MD:National Institutes of Health. Available: http://grants.nih.
gov/grants/olaw/references/PHSPolicyLabAnimals.pdf
[accessed 25 February 2007].
Patil C, Walter P. 2001. Intracellular signaling from the endoplas-
mic reticulum to the nucleus: the unfolded protein response
in yeast and mammals. Curr Opin Cell Biol 13:349–355.
Payne C, Crowley-Weber C, Dvorak K, Bernstein C, Bernstein H,
Holubec H, et al. 2005. Mitochondrial perturbation attenu-
ates bile acid-induced cytotoxicity. Cell Biol Toxicol
21:215–231.
Ratra GS, Cottrell S, Powell CJ. 1998a. Effects of induction and
inhibition of cytochromes P450 on the hepatotoxicity of
methapyrilene. Toxicol Sci 46:185–196.
Ratra GS, Morgan WA, Mullervy J, Powell CJ, Wright MC.
1998b. Methapyrilene hepatotoxicity is associated with
oxidative stress, mitochondrial disfunction and is pre-
vented by the Ca2+ channel blocker verapamil. Toxicology
130:79–93.
Ratra GS, Powell CJ, Park BK, Maggs JL, Cottrell S. 2000.
Methapyrilene hepatotoxicity is associated with increased
hepatic glutathione, the formation of glucuronide conju-
gates, and enterohepatic recirculation. Chem Biol Interact
129:279–295.
Ruepp SU, Tonge RP, Shaw J, Wallis N, Pognan F. 2002.
Genomics and proteomics analysis of acetaminophen toxi-
city in mouse liver. Toxicol Sci 65:135–150.
Schroder M, Kaufman RJ. 2005. The mammalian unfolded pro-
tein response. Annu Rev Biochem 74:739–789.
Staudinger JL, Goodwin B, Jones SA, Hawkins-Brown D,
MacKenzie KI, LaTour A, et al. 2001. The nuclear receptor
PXR is a lithocholic acid sensor that protects against liver
toxicity. Proc Natl Acad Sci USA 98:3369–3374.
Stedman CAM, Liddle C, Coulter SA, Sonoda J, Alvarez JGA,
Moore DD, et al. 2005. Nuclear receptors constitutive
androstane receptor and pregnane X receptor ameliorate
cholestatic liver injury. Proc Natl Acad Sci USA 102:
2063–2068.
Waring JF, Ulrich RG, Flint N, Morﬁtt D, Kalkuhl A, Staedtler F,
et al. 2004. Interlaboratory evaluation of rat hepatic gene
expression changes induced by methapyrilene. Environ
Health Perspect 112:439–448.
Waters MD, Fostel JM. 2004. Toxicogenomics and systems tox-
icology: aims and prospects. Nat Rev Genet 5:936–948.
Wei P, Zhang J, Dowhan DH, Han Y, Moore DD. 2002. Speciﬁc
and overlapping functions of the nuclear hormone receptors
CAR and PXR in xenobiotic response. Pharmacogenomics J
2:117–126.
Wei Y, Wang D, Topczewski F, Pagliassotti MJ. 2006. Saturated
fatty acids induce endoplasmic reticulum stress and apop-
tosis independently of ceramide in liver cells. Am J Physiol
Endocrinol Metab 291(2):E275–E278. [Epub 2006 Feb 2].
Weis BK, Consortium MotTR. 2005. Standardizing global gene
expression analysis between laboratories and across plat-
forms. Nat Methods 2:351–356.
Weng L, Dai H, Zhan Y, He Y, Stepaniants SB, Bassett DE. 2006.
Rosetta error model for gene expression analysis.
Bioinformatics 22:1111–1121.
Wrighton SA, VandenBranden M, Brown TJ, Van Pelt CS,
THomas PE, Shipley LA. 1991. Modulation of rat hepatic
cytochromes P450 by chronic methapyrilene treatment.
Biochem Pharmacol 42:1093–1097.
Xie W, Barwick JL, Downes M, Blumberg B, Simon CM, Nelson
MC, et al. 2000. Humanized xenobiotic response in mice
expressing nuclear receptor SXR. Nature 406:435–439.
Zhou T, Chou JW, Simpson DA, Zhou Y, Mullen TE, Medeiros M,
et al. 2006. Profiles of global gene expression in ionizing-
radiation-damaged human diploid fibroblasts reveal syn-
chronization behind the G1 checkpoint in a G0-like state of
quiescence. Environ Health Perspect 114:553–559.